Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What's so special about the developing immune system?

Leigh Ann Burns-Naas1, Kenneth L Hastings, Gregory S Ladics

  • 1Drug Safety Research and Development, Pfizer Global Research and Development, California, USA. leighann.burns@pfizer.com

International Journal of Toxicology
|April 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological profiling of intravenous MP-04: sustained NAD<sup>+</sup> augmentation, immune modulation, and renal protection in preclinical models.

Frontiers in pharmacology·2026
Same author

Safety evaluation of a fungal beta-glucanase.

Toxicology reports·2025
Same author

Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendations.

Regulatory toxicology and pharmacology : RTP·2024
Same author

Determination of OTNE-induced thyroid effects within an adverse outcome pathway (AOP) network.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2024
Same author

Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.

Frontiers in toxicology·2024
Same author

Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2023
Same journal

Safety Assessment of <i>Melaleuca alternifolia</i> (Tea Tree)-Derived Ingredients as Used in Cosmetics.

International journal of toxicology·2026
Same journal

Safety Assessment of Radish Root - Derived Ingredients as Used in Cosmetics.

International journal of toxicology·2026
Same journal

Aldose Reductase Inhibitor, Epalrestat, Suppresses Colorectal Cancer Cell Proliferation Through Complement-Dependent Cytotoxicity.

International journal of toxicology·2026
Same journal

Nonclinical Safety Profiles of mRNA Therapeutics Comprising Unmodified or N1-Methyl-Pseudouridine-Modified Nucleosides Are Similar Following Repeated Administration.

International journal of toxicology·2026
Same journal

Amended Safety Assessment of Naturally-Sourced Clays as Used in Cosmetics.

International journal of toxicology·2026
Same journal

Evaluation of the <i>in vitro</i> Toxicity of Novel Oxime Acetylcholinesterase Reactivators.

International journal of toxicology·2026
See all related articles

Developmental immunotoxicology (DIT) has evolved due to regulations and science, focusing on children's unique immune system vulnerabilities. Further research is needed to improve DIT assessments in humans.

Area of Science:

  • Immunotoxicology
  • Developmental Biology

Background:

  • Developmental immunotoxicology (DIT) has been significantly influenced by regulatory demands and scientific progress.
  • The developing immune system exhibits unique susceptibilities compared to adult systems, necessitating specialized attention.

Purpose of the Study:

  • To review the current state of developmental immunotoxicology science.
  • To examine the impact of legislation and scientific advances on DIT.
  • To highlight the need for improved DIT assessment methods in humans.

Main Methods:

  • Literature review focusing on regulatory influences, scientific advances, and species differences in immune development.
  • Analysis of data on immune system development during critical life stages.
  • Emphasis on the role of pathology in DIT studies and integration with DART protocols.

Related Experiment Videos

Main Results:

  • Legislation and scientific progress have shaped DIT, with a growing recognition of the developing immune system's unique vulnerabilities.
  • Challenges in DIT include data scarcity on immune development and interspecies differences in timing and anatomy.
  • Beyond immunosuppression, DIT research must consider effects like allergy and autoimmunity.

Conclusions:

  • Developmental immunotoxicology is an evolving field with ongoing progress.
  • Improved understanding and methods are crucial for assessing DIT risks in humans.
  • Integrating pathology evaluations into DART protocols could enhance DIT assessments.